GLUE
#2351
Monte Rosa Therapeutics, Inc. - Common Stock
13.6 6 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.61%
Variación mensual
-38.55%
Variación en los últimos 6 meses
-20.63%
Cambio anual
+20.88%
Cierres anteriores
14.3 2
Open
13.6 7
Mínimo
13.6 3
Máximo
13.7 5
Volumen
199
Financials
- Market Capitalization 1.17 B
- Employee 173
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-33.72
Relación precio/flujo de caja
10.53
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2318 |  IMTX Immatics N.V. - Ordinary Shares | 9.65 USD | +3.10% | +8.92% | +11.18% | -6.76% | 1.29 B USD | ||
| 2334 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.96 USD | -3.18% | +2.59% | +20.73% | +30.69% | 1.19 B USD | ||
| 2356 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.15 USD | -3.87% | -2.55% | +5.91% | +161.07% | 1.19 B USD | ||
| 2372 |  KURA Kura Oncology, Inc. - Common Stock | 12.73 USD | -3.41% | +7.61% | +37.18% | +56.58% | 1.13 B USD |